+41 91 682 20 40
info@elixi-int.com
Reserved Area
Login
Register
Request Document
Send Document
Home
About Us
Services
Quality
News
Case Studies
Contact
Online Store
Let's talk
info@yourwebsite.com
+1 (555) 123-4567
Search
compensated cirrhosis
1 October 2019
Mavyret (glecaprevir and pibrentasvir), a treatment for adults and children with all genotypes of hepatitis C and compensated cirrhosis, shortens the duration of treatment to eight weeks
by Elixi